Clinical Trials Logo

Obesity clinical trials

View clinical trials related to Obesity.

Filter by:

NCT ID: NCT05706155 Recruiting - Obesity Clinical Trials

Effect of Partial Dietary Replacement From Animal to Plant-Based Protein for Type 2 Diabetes Management

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to examine the effect plant-based diet, with a partial replacement of animal protein by plant protein, in blood sugar levels and other health risks of people with type 2 diabetes and excessive weight. The plant-based diet will be compared to a standard healthy diet according to guidelines for people with diabetes. Participants will follow a plant-based or a standard healthy diet for 24 weeks and will maintain their habitual levels of physical activity.

NCT ID: NCT05705388 Recruiting - Obesity Clinical Trials

POSE2.0 With GLP-1 Agonist for Obesity Management

Start date: January 16, 2023
Phase: N/A
Study type: Interventional

Determine the effect on weight loss and obesity-related comorbidities in patients receiving the POSE 2.0 procedure with sequential use of Liraglutide at 6 months compared to those receiving Liraglutide and then undergoing the POSE 2.0 procedure at 6 months.

NCT ID: NCT05705245 Recruiting - Obesity Clinical Trials

Effects of Recruitment Manouever on Oxygenation, Oxygen Reserve Index and Postoperative Pulmonary Complications

Start date: January 22, 2022
Phase:
Study type: Observational

General anesthesia and mechanical ventilation decrease pulmonar volume; attenuate small airway closure, atelectasis, and increase the rate of hypoxia and postoperative pulmonary complications. Lung volume in obese patients decreases inversely with the increase in body mass index. Obesity is associated with increased atelectasis, hypoxia and postoperative pulmonary complication rates during anesthesia . Alveolar recruitment maneuver is a technique where high positive end-expiratory pressure (PEEP) is applied for for short periods, follwed by a continuous PEEP app┼čication throughout surgery. This has become a standard practice during anesthesia in recent years. Oxygen reserve index (ORi) is an index measured with a non-invasive finger-tip sensor and shows the oxygen content of the venous blood. It is effective at high oxygen levels and may indicate the presence of hyperoxia. Our aim is to examine the effect of alveolar recruitment maneuver on oxygenation parameters under anesthesia and the correlation with ORi in morbidly obese patients.

NCT ID: NCT05705063 Not yet recruiting - Obesity Clinical Trials

Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness

Start date: January 30, 2023
Phase: N/A
Study type: Interventional

To initiate a low-carbohydrate, high-fat (LCHF) or ketogenic dietary (KD) intervention among a cohort of outpatients with bipolar illness who also have metabolic abnormalities, overweight/obesity, and/or are currently taking psychotropic medications experiencing metabolic side effects.

NCT ID: NCT05703347 Not yet recruiting - Obesity Clinical Trials

Optimizing a Mobile Health Platform for Sleep Promotion and Obesity Prevention in Children

Start date: March 2023
Phase: N/A
Study type: Interventional

The overall objective of this application is to develop a mobile health platform for the pediatric care setting to promote longer sleep duration for childhood obesity prevention.

NCT ID: NCT05702840 Not yet recruiting - Clinical trials for Overweight and Obesity

EXerCise wEight Loss

EXCEL
Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The overall aim of this study is to investigate the effects of home-based resistance exercise programme on changes in body composition and strength during weight loss, in people living with obesity or overweight.

NCT ID: NCT05702112 Not yet recruiting - Obesity Clinical Trials

Association of Triglyceride-glucose Index With Cardiac Hemodynamics

Start date: March 2023
Phase:
Study type: Observational

1) To estimate the prevelance of IR in obese patients based on TYG index . 2) To screen early cardiovascular abnormalities in obese asymptomatic patients using conventional echocardiography and electrocardiogram . 3) To detect association of cardiovascular hemodynamics with TyG index . Assess cardiovascular risk in obese patients .

NCT ID: NCT05701813 Not yet recruiting - Obesity Clinical Trials

The Study Aims to Investigate the Effects of Oral Inositols on Insulin-resistance in Children With Obesity.

ONIRICO
Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The study aims to investigate the effects of oral inositols on insulin-resistance and metabolic variables (triglycerides, total cholesterol, HDL cholesterol) in children aged 8-12 years with obesity and insulin-resistance.

NCT ID: NCT05700916 Not yet recruiting - Obesity Clinical Trials

Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

Start date: February 2023
Phase: Early Phase 1
Study type: Interventional

The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.

NCT ID: NCT05700409 Recruiting - Obesity, Childhood Clinical Trials

Evaluating a Telemedicine-based Intensive Treatment Program for Children and Adolescents With Obesity

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The study objective is to evaluate whether a novel telemedicine-based intensive treatment program for children with obesity is superior to standard on-site care. This will be a randomized, non-blinded (due to the nature of the intervention) study, where 100 children and adolescents aged 10-18 years with obesity will be divided in a 1:1 ratio to either telemedicine or on-site treatments for 6 months. The telemedicine arm will include 30, mostly video, consultations for each participant: 3 physician appointments, 7 exercise consultations by our exercise physiologist, 10 dietary consultations by our pediatric dietitian, and 10 psychologist consultations to assist with goal setting and overall well-being. Three visits will be conducted in-office, for physician assessment, smartphone technical assistance and physical measurements (baseline, at 3 months and at the end of the 6-month period). Participants randomized to the telemedicine arm will have a step-counting rewarding app installed on their smartphone by our staff. The in-office arm will have 6 monthly visits during the study period, with two consultations performed in each visit - one by the physician or exercise physiologist, and one by our pediatric dietitian. The main outcome of the study is BMI standard deviation (z-score) changes, which will be evaluated after 3 and 6 months of treatment during physical office visits in both study arms. Secondary outcomes will be: - Body-fat percent changes, assessed by bioimpedance analysis in physical clinic visits. - Daily step counts, measured by smartphone data/ wearable activity tracker, if available. - Weight-related quality of life - Retention and visit cancellation rates. - Satisfaction of both parent and child from their allocated treatment.